Tagged with GE

Pfizer Argentina You were General Manager of Pfizer Peru and Pfizer Venezuela before taking on the challenge of the Argentinean market. How difficult was the experience of adjusting to this unique environment? One of the things that a manager learns quickly in Latin America is how to deal with the volatility and…

Argentine Ministry of Science ¿Porque fue creado en Ministerio de Ciencia y Tecnología, con que visión? Muchos países están aportando importancia a la ciencia y tecnología y representa la razón del desarrollo económico y social de esos mismos países. El ministerio en Argentina se creó en ese sentido, para ayudar a transformar el conocimiento…

Baxter Germany Next year Baxter will accomplish its 50th anniversary in Germany. In the context of its celebration, what would you highlight as the main achievements of the company especially since you took the reigns of the German operations? Baxter Germany has grown steadily in the German market primarily thanks to its…

DKFZ - German Cancer Research Center The DKFZ – German Cancer Research Center – is Germany’s largest cancer research institute with an international recognition recently coroneted with the Nobel Prize to Mr Harald zur Hausen for the HPV vaccine. What were the set of values and visions that allowed the DKEZ to have such a prominent…

Janssen-Cilag Argentina When we spoke to Javier Lombar of IMS Argentina, he explained that a lot of multinational companies use Argentina as a base for regional operations. How does Janssen-Cilag operate in this Latin American context, and what role does the Argentinean operation play in Janssen-Cilag’s plans? Janssen-Cilag sees the pharmaceutical business…

TEVA Germany The acquisition of IVAX in 2006 was decisive to establish Teva as the number one generic producer worldwide and further consolidate the company in the German market; and this process continued with the recent acquisition of AWD Pharma in 2008. What as the impact of such acquisitions in your German…

Astellas Pharma Germany Astellas has been present in the German market for almost two decades through Yamanouchi and Fujisawa. But since 2005 it gained a new identity thanks to the merger of the two companies. Could you describe their integration process in Germany and which were the main synergies in the local market?…

ProGenerika The German Pharmaceutical Industry is not only known for its cutting-edge R&D and production base but also for having a high penetration of generics. In your opinion, what role do generics play in the German pharmaceutical market and how have they managed to achieve such a wide penetration? Generics play…

Cegedim Dendrite South Korea You have been working in the CRM industry, particularly with pharmaceutical companies, for more then 10 years. Could you briefly introduce to our readers how the CRM industry has evolved in South Korea throughout this period? I understand that ETMS (Electronic Territory Management System) was introduced to Korea in late…

Anugerah Corporation The development of the Local Pharmaceutical industry companies has gone through rough times, competing from the very beginning with MNCs and going through the economic shock in the 90’s. In this period while many companies couldn’t cope with the market competition, Anguerah Corporation succeeded in positioning itself as one of…

Bausch & Lomb Germany With a wide experience in other international pharmaceutical companies, what attracted you to come to Bausch&Lomb, the ophthalmology pharma company? Bausch&Lomb offered me a unique set of challenges and possibilities that no other company could thanks to its own transformations and special needs. Since Bausch&Lomb changed ownership in 2007, our…

Gilead Sciences Germany Gilead was founded in 1987 and only four years later it established itself in the German market. Since then the company has become internationally known for breakthroughs that resulted in products such as Tamiflu, Viread and Atripla. What would you highlight as the main achievements of the company in the…